National Institute of Child Health and Human Development
Maternal Fetal Medicine Units Network

Publications & Presentations
Fetal Fibronectin RCT

Publications

1. Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, Leveno KJ, Wapner R, Moawad A, O'Sullivan MJ, Caritis SN, Iams JD, Langer O, Miodovnik M, Dombrowski M and the NICHD MFMU Network. A randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstetrics & Gynecology, 101: 847-855, 2003.

Presentations

1. Andrews WW for the NICHD MFMU Network. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin positive women. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigators, Toronto, CA, March 2001.



2. Ramsey P. for the NICHD MFMU Network. Relationship of midtrimester fetal fibronectin (FFN) concentration to antibiotic efficacy for the prevention of spontaneous preterm birth In asymptomatic fFN positive women. Presented at the 25th Annual Meeting of the Society for Maternal-Fetal Medicine, Reno, NV, February 2005.



3. Hendler I. for the NICHD MFMU Network. The relationship between resolution of asymptomatic Bacterial Vaginosis and spontaneous preterm birth in fetal Fibronectin positive women. Presented at the 25th Annual Meeting of the Society for Maternal-Fetal Medicine, Reno, NV, February 2005.



4. Lin M for the NICHD MFMU Network. Impact of quantitative fetal fibronectin (FFN) change on efficacy of antibiotic vs. placebo treatment of asymptomatic FFN positive women to prevent subsequent preterm birth (PB). Presented at the 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami Beach, FL, January 2006.